NCT04136483

Brief Summary

The study is a clinical pilot study that examine the preliminary effect of cognitive-behavioral therapy for insomnia (CBT-I) in adolescents with comorbid psychiatric disorders. Participants (n=25) are recruited from three psychiatric clinics (n=19) and one pediatric pain clinic (n=6). After diagnostic assessment, participants that fulfil inclusion criteria are offered the CBT-I intervention. Pre-post and 3-months follow-up assessments include subjective measures of insomnia symptom severity, sleep parameters (collected through sleep-wake diaries), symptoms of depression and anxiety and daytime functioning.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2015

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2018

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

September 3, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 23, 2019

Completed
Last Updated

October 23, 2019

Status Verified

October 1, 2019

Enrollment Period

2.8 years

First QC Date

September 3, 2019

Last Update Submit

October 22, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline Insomnia Severity Index- adolescent version (ISI-a)

    The Insomnia Severity Index, ISI -adolescent version18 was used before, after at three months follow-up to measure insomnia symptom severity. ISI-a is an adaptation to adolescents of the Insomnia Severity Index32,36. ISI-a is a seven-item measure that yields a quantitative index of sleep impairment and treatment outcome. Total scores range from 0 to 28, with higher scores indicating greater perceived insomnia severity.

    6 weeks and 3 months

Secondary Outcomes (6)

  • Sleep Onset Latency (SOL)

    Baseline, 6 weeks and 3 months

  • Wake after sleep onset (WASO)

    Baseline, 6 weeks and 3 months

  • Total Sleep Time (TST)

    Baseline, 6 weeks and 3 months

  • Sleep Efficiency (SE)

    Baseline, 6 weeks and 3 months

  • Spences' Children Anxiety Scale (SCAS)

    Baseline, 6 weeks and 3 months

  • +1 more secondary outcomes

Study Arms (1)

CBT-I

EXPERIMENTAL
Behavioral: CBT-I

Interventions

CBT-IBEHAVIORAL

The theoretical framework is cognitive-behavioral therapy that includes sleep education, sleep hygiene, sleep restriction, stimulus control, cognitive interventions and relaxation. The intervention has been adapted to adolescents by reducing the amount of psychoeducational information and the interventions related to changing cognitions. It involves six weekly face-to-face individual sessions with a therapist, supported by a participant workbook that contains information, work- sheets, and at-home tasks. Clinical psychologists or graduate clinical psychologists in training delivered the intervention sessions under supervision by the first author. Parents/care-givers were given information about the components, but did not take active part of the intervention.

CBT-I

Eligibility Criteria

Age13 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • be between 13-17 years old
  • meet criteria for insomnia disorder (primary or secondary insomnia) according to DSM-IV-TR
  • have insomnia symptoms at a clinical level, as defined as more than 10 points on the ISI-a
  • adequate Swedish language skills

You may not qualify if:

  • severe psychiatric disorder that is contraindicative of the treatment (i.e., bipolar disorder, psychotic disorder)
  • autistic disorder
  • severe suicidality (defined as ≥17 points on MINI-kid suicide subscale)
  • alcohol or drug dependence
  • psychotropic medication
  • previous (\> 5 sessions) or ongoing CBT-treatment for insomnia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Mats Lekander, Professor

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 3, 2019

First Posted

October 23, 2019

Study Start

April 1, 2015

Primary Completion

December 31, 2017

Study Completion

January 30, 2018

Last Updated

October 23, 2019

Record last verified: 2019-10